← Back to Search

Behavioural Intervention

Empathetic Communication for Patient Preference

Rochester, MN
N/A
Waitlist Available
Led By April Christensen, MD, MS
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients over the age of 18 being seen in palliative care clinic who have already established care and with diagnosis of any malignancy
Be older than 18 years old
Must not have
Inability to consent defined as: Acute mental status changes (delirium/encephalopathy), acute substance intoxication, intellectual disability, dementia, patient with active legal guardian
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if patients prefer talking to a human or AI for empathetic communication, and whether knowing who is speaking affects their preference.

See full description
Who is the study for?
This trial is for individuals interested in participating in a study about communication preferences. There are no specific inclusion or exclusion criteria provided, which suggests that the study may be open to a broad adult population.Check my eligibility
What is being tested?
The trial is testing patient preferences for empathetic communication authored by AI versus humans. Participants will likely take surveys where they'll evaluate messages without knowing who wrote them and then again with that knowledge.See study design
What are the potential side effects?
Since this study involves taking surveys on communication preferences, there are no direct medical side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18, seeing a palliative care doctor, and have been diagnosed with cancer.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am able to understand and consent to my own medical treatment.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Preference patterns for empathetic communication

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Survey Group - UnblindedExperimental Treatment1 Intervention
Participants will be informed of origin of survey statements
Group II: Survey Group - BlindedExperimental Treatment1 Intervention
Participants will be blinded to origin of survey statements

Find a Location

Closest Location:Mayo Clinic in Rochester· Rochester, MN· 516 miles

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,411 Previous Clinical Trials
3,208,528 Total Patients Enrolled
April Christensen, MD, MSPrincipal InvestigatorMayo Clinic in Rochester
~133 spots leftby Jun 2025